V. Ravery
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Kidney Stones and Urolithiasis Treatments
- Renal cell carcinoma treatment
- Urology top 1%
- Urological Disorders and Treatments
Papers in
-
- Prostate Cancer Diagnosis and Treatment 78
- Prostate Cancer Treatment and Research 40
- Surgery 34
- Bladder and Urothelial Cancer Treatments 26
- Urinary and Genital Oncology Studies 10
- Co-authors
- L Boccon-Gibod (44 shared papers)M Toublanc (31 shared papers)V. Delmas (30 shared papers)L. Boccon‐Gibod (8 shared papers)Bob Djavan (21 shared papers)Michael Marberger (20 shared papers)Michaël Peyromaure (8 shared papers)Mesut Remzi (9 shared papers)
In The Last Decade
V. Ravery
146 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 103
- Pulmonary and Respiratory Medicine 2.2k
- Urology 264
- Rheumatology 444
- Cancer Research 328
- Surgery 835
Countries citing papers authored by V. Ravery
This map shows the geographic impact of V. Ravery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Ravery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Ravery more than expected).
Fields of papers citing papers by V. Ravery
This network shows the impact of papers produced by V. Ravery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Ravery. The network helps show where V. Ravery may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Ravery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 160 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 324 | |
| 2 | High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. | 1996 | 163 |
| 3 | 1994 | 139 | |
| 4 | 2000 | 132 | |
| 5 | 2012 | 115 | |
| 6 | 1999 | 108 | |
| 7 | 1993 | 99 | |
| 8 | 2002 | 88 | |
| 9 | 2002 | 87 | |
| 10 | Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer. | 1999 | 86 |
| 11 | 2004 | 82 | |
| 12 | 2002 | 81 | |
| 13 | 2001 | 73 | |
| 14 | 2001 | 72 | |
| 15 | 2002 | 72 | |
| 16 | 2013 | 70 | |
| 17 | 1998 | 68 | |
| 18 | 2000 | 67 | |
| 19 | 2005 | 66 | |
| 20 | 1996 | 65 |
About V. Ravery
V. Ravery is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Rheumatology, Urology and Molecular Biology, having authored 160 papers that have together received 3.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (78 papers), Prostate Cancer Treatment and Research (40 papers), Bladder and Urothelial Cancer Treatments (26 papers), Urologic and reproductive health conditions (19 papers), Urological Disorders and Treatments (16 papers), Urinary Bladder and Prostate Research (10 papers), Urinary and Genital Oncology Studies (10 papers) and Pelvic floor disorders treatments (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Urology (264 citations), Rheumatology (444 citations), Cancer Research (328 citations) and Surgery (835 citations). V. Ravery has collaborated with scholars based in France, Austria and Germany. Frequent co-authors include L Boccon-Gibod, M Toublanc, V. Delmas, L. Boccon‐Gibod, Bob Djavan, Michael Marberger, Michaël Peyromaure, Mesut Remzi, Jean‐François Hermieu and Axel Heidenreich. Their work appears in journals such as The Journal of Urology, European Urology, Urology, British Journal of Urology and Journal of Endourology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.